Print Page

Medicine recalls

 
Canada: Recall: NRA-Amlodipine 5 mg tablets: One lot recalled as some bottles may contain the wrong drug
 
Health Canada announces that Nora Pharma is recalling one lot of NRA-Amlodipine 5 mg tablets (lot number: EM240229) because some bottles may contain the wrong tablets, which have been identified as metoprolol succinate prolonged-release 12.5 mg tablets.

NRA-Amlodipine treats high blood pressure and chest pain in adults and children aged 6 to 17. The tablets are white or off-white, octagonal, flat, and scored in the middle with '210' and '5' on one side.

The metoprolol succinate prolonged-release 12.5 mg tablets are white, round and scored in the middle. While metoprolol is also used to treat high blood pressure and chest pain, substituting amlodipine (5 mg) with metoprolol (12.5 mg) can lead to serious side effects such as dangerous blood pressure changes (especially dangerously low drops), difficulty breathing, or an abnormally slow heart rate. Patients with other conditions (especially heart failure, asthma, severe peripheral arterial disease, pheochromocytoma, or diabetes) and those taking other medications could experience different side effects with varying levels of severity. Children taking the wrong medication may face a higher risk of serious side effects and potential harm.

Please refer to the following website in Health Canada for details: http://recalls-rappels.canada.ca/en/alert-recall/nra-amlodipine-5-mg-tablets-one-lot-recalled-some-bottles-may-contain-wrong-drug

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/Monday, Jul 7, 2025
Issued at HKT 15:15
 
 
back